Results 1 to 10 of about 136,303 (402)

Atrial natriuretic factor [PDF]

Current Opinion in Cardiology, 1987
The discovery of the first well-defined natriuretic hormone, the Atrial Natriuretic Factor (ANF), has prompted research on its impact on volume regulation in health and disease.
A.L. Gerbes, Ames, Anderson, Anderson, Arendt, Arendt, Arendt, Arendt, Atlas, Ballermann, Ballermann, Barakat, Bichet, Bichet, Biollaz, Bompiani, Bonkovsky, Bourgoignie, Brabant, Bricker, Buckalew, Burghardt, Burnett, Campbell, Chartier, Conn, Cuneo, Currie, De Wardener, DeBold, DeBold, DeWardener, Epstein, Epstein, Epstein, Epstein, Epstein, Fernandez-Cruz, Forssmann, Fyhrquist, G. Paumgartner, Ganger, Gauer, Gerbes, Gerbes, Gerbes, Gerbes, Gerbes, Gerbes, Gerbes, Gerzer, Gerzer, Ginés, Goodfriend, Hartshorne, Henry, Jimenez, Jüppner, Kisch, Kramer, Laffi, Lang, Laragh, Maack, Manning, Marin-Grez, Morgan, Naruse, Needleman, Needleman, Nishiuchi, Nozuki, Ogihara, R.M. Arendt, Renner, Richards, Richards, Richards, Riegger, Ring-Larsen, Rosoff, Sagnella, Sagnella, Salerno, Samson, Schafferhans, Shenker, Sherlock, Shimizu, Thibault, Tikkanen, Uehlinger, Valdivieso, Wambach, Weidmann, Wernze, Wilkinson, Wong, Yamaji, Zipser   +99 more
core   +8 more sources

Augmentation of the natriuretic response to atrial natriuretic factor in cirrhosis [PDF]

Hepatology, 1989
The effects of atrial natriuretic factor (ANF) on splanchnic hemodynamics and renal function in portal hypertensive models are described incompletely. Furthermore, ANF–induced vasodilatation and hypotension may limit the assessment of its own renal physiological effects.
Gerbes, Gerbes, Gerbes, Laffi, Lenz, Petrillo, Salerno   +6 more
core   +5 more sources

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background We tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident atrial fibrillation (AF) in a prospective study of chronic kidney disease patients.
Julio A. Lamprea‐Montealegre, Leila R. Zelnick, Michael G. Shlipak, James S. Floyd, Amanda H. Anderson, Jiang He, Rob Christenson, Stephen L. Seliger, Elsayed Z. Soliman, Rajat Deo, Bonnie Ky, Harold I. Feldman, John W. Kusek, Christopher R. deFilippi, Myles S. Wolf, Tariq Shafi, Alan S. Go, Nisha Bansal   +17 more
doaj   +3 more sources

Plasma atrial natriuretic factor in patients with cirrhosis [PDF]

, 1985
Arendt, Rainer M., Gerbes, Alexander L., Jüngst, Dieter, Paumgartner, Gustav, Ritter, D., Zähringer, J.   +5 more
core   +3 more sources

Atrial Natriuretic Factor

Journal of Biological Chemistry, 1989
ANF is an exciting, newly discovered hormone that has significant potential for furthering our understanding of the complex interactions involved in fluid and electrolyte balance. In addition to effects on water and salt balance, it is a potent vasodilator, as well as inhibitor of renin, angiotensin II, aldosterone, and vasopressin.
Lewis Hm, R A W Stott, Martin R. Wilkins
  +12 more sources

Atrial Natriuretic Peptide31–67: A Novel Therapeutic Factor for Cardiovascular Diseases

Frontiers in Physiology, 2021
The characterization of the cardiac hormone atrial natriuretic peptide (ANP99–126), synthesized and secreted predominantly by atrial myocytes under stimulation by mechanical stretch, has established the heart as an endocrine organ with potent natriuretic,
Gustavo Jose Justo da Silva, Raffaele Altara, Raffaele Altara, George W. Booz, Alessandro Cataliotti   +4 more
doaj   +1 more source

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Chagas disease (CD) presents an ominous prognosis. The predictive value of biomarkers and new echocardiogram parameters in adjusted models have not been well studied.
Veronica G. Mendes, Lorena Rimolo, Ana Carolina B. de Lima, Roberto R. Ferreira, Luciano S. Oliveira, Lindice M. Nisimura, Samuel I. M. Horita, Andréa R. Costa, Gilberto Marcelo S. da Silva, Luiz Henrique C. Sangenis, Fernanda S. N. S. Mendes, Andrea S. Sousa, Henrique H. Veloso, Marcelo T. Holanda, Mauro F. F. Mediano, Mariana C. Waghabi, Luciana R. Garzoni, Otacílio C. Moreira, Constança Britto, Ademir B. Cunha, Alejandro Marcel Hasslocher‐Moreno, Roberto M. Saraiva   +21 more
doaj   +1 more source

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways [PDF]

Iranian Journal of Basic Medical Sciences, 2023
Objective(s): Irisin was reported as a cardioprotective and anti-oxidative effector, while the effect on atrial fibrosis is unknown. The current research examined irisin’s function in atrial fibrillation (AF); atrial fibrosis brought on by Ang II can be ...
Yingbiao Wu, Jun Luo, Xiang Song, Wei Gu, Saihua Wang, Shuwen Hao, Zhiwu Dong, Zhongping Ning   +7 more
doaj   +1 more source

Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes. [PDF]

PLoS Neglected Tropical Diseases, 2013
Trypanosoma cruzi, the causative agent of Chagas' disease, induces multiple responses in the heart, a critical organ of infection and pathology in the host.
Ricardo S Corral, Néstor A Guerrero, Henar Cuervo, Núria Gironès, Manuel Fresno   +4 more
doaj   +1 more source

NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond

Biology, 2022
Reactivation of fetal cardiac genes, including those encoding atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), is a key feature of pathological cardiac remodeling and heart failure.
Hideaki Inazumi, Koichiro Kuwahara
doaj   +1 more source